How to take Mobosetinib/Mobosetinib

Mobocertinib/Mobocertinib is a targeted therapy drug specially designed for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations. The method of taking it is particularly important to ensure the effectiveness and safety of the drug. Before deciding whether to use moboxetinib, doctors will first evaluate whether the patient has an EGFR exon 20 insertion mutation, and select suitable patients with locally advanced or metastatic non-small cell lung cancer for treatment based on the presence of this mutation.

Before officially starting treatment, doctors will perform a thorough evaluation of the patient, including an electrocardiogram to monitor the QTc interval, and blood tests to assess electrolyte levels. This step is critical because electrolyte imbalances (such as abnormalities in sodium, potassium, calcium, and magnesium) may affect drug metabolism and patient safety. Therefore, doctors will take steps to correct these abnormalities when necessary to ensure safe and effective treatment for patients.

The recommended dosage of mobosetinib is 160 mg orally once daily. Patients should continue to take it until disease progression occurs or adverse reactions reach an unacceptable level. In terms of taking time, patients should take it at the same time every day, whether with food or on an empty stomach. Patients must swallow the capsule completely when taking it, and do not open, chew or dissolve the contents of the capsule to avoid affecting the release and absorption of the drug.

During treatment, patients may experience some adverse reactions. If adverse reactions occur, the doctor will adjust the drug dose in a timely manner according to the severity of the symptoms to ensure the patient's safety and comfort. For example, the initial dose can be reduced to 120 mg orally once a day as needed, and if significant side effects still exist, the second dose can be further reduced to 80 mg orally once a day. Through this flexible dose adjustment strategy, doctors can personalize treatment plans based on patients' specific responses and improve the tolerability and effectiveness of treatment.